Abstract
Background
Growing evidences highlight the role of the innate immune response in the pathogenesis of type 1 diabetes (T1D) vascular complications. Neutrophil lymphocytic ratio (NLR) and platelet lymphocytic ratio (PLR) are inexpensive but novel markers of chronic inflammation might have prognostic value in children with T1D.
Aim
To study NLR and PLR levels in children with T1D in comparison to matched controls and correlate them with fraction-C of glycosylated hemoglobin (HbA1C) and micro-vascular complications.
Methodology
Hundred children with T1D were compared to 100 matched healthy controls. History included diabetes duration, insulin dose and frequency of hypoglycemic attacks. Fundus examination and the simple rapid neuropathy disability score were done. HbA1C, fasting lipids, urinary albumin excretion and complete blood count were measured with assessment of NLR and PLR
Results
NLR was significantly higher (p = 0.008) and PLR was significantly lower (p = 0.007) in children with T1D than controls. NLR was positively correlated while PLR was negatively correlated with HbA1C, diabetes duration, fasting cholesterol, triglycerides and LDL. NLR was significantly higher (p < 0.001) and PLR was significantly lower (p = 0.005) in children with microvascular complications than those without. Moreover, multivariate logistic regression revealed that microvascular complications were independently associated with NLR (p = 0.013) and PLR (p = 0.004).
Conclusion
Children with T1D had significantly higher NLR and lower PLR compared to controls. These changes were more evident in those with diabetic microvascular complications than those without. Furthermore, NLR was positively correlated and PLR was negatively correlated to HbA1C, diabetes duration and hyperlipidemia. Hence, NLR and PLR can be a potential indicator for the risk of development of diabetic microvascular complications in children with T1D.
Similar content being viewed by others
Availability of data and material
Data will be available upon request.
Code availability
N/A.
Abbreviations
- CRP:
-
C-reactive protein
- HbA1C:
-
Fraction C of glycated hemoglobin
- NDS:
-
Bedside neuropathy disability score
- NLR:
-
Neutrophil–lymphocyte count ratio
- PLR:
-
Platelet–lymphocyte count ratio
- SMBG:
-
Self-monitoring of blood glucose
- T1D:
-
Type 1 diabetes
- T2D:
-
Type 2 diabetes
- UAER:
-
Urinary albumin excretion ratio
References
Gliwiński M, Iwaszkiewicz-Grześ D, Wołoszyn-Durkiewicz A, Tarnowska M, Żalińska M, Hennig M, Zielińska H, Dukat-Mazurek A, Zielkowska-Dębska J, Zieliński M, Jaźwińska-Curyłło A, Owczuk R, Jarosz-Chobot P, Bossowski A, Szadkowska A, Młynarski W, Marek-Trzonkowska N, Moszkowska G, Siebert J, Myśliwiec M, Trzonkowski P. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy. BMJ Open Diabetes Res Care. 2020;8:e000873. https://doi.org/10.1136/bmjdrc-2019-000873.
Graves L, Donaghue K. Vascular complication in adolescents with diabetes mellitus. Front Endocrinol. 2020;11:340. https://doi.org/10.3389/fendo.2020.00370.
Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20:9. https://doi.org/10.1186/s12933-020-01200-7.
Mendes B, Oliveira A, Alcântara K. Comparison of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in normoglycemic and hyperglycemic subjects. Einstein (Sao Paulo). 2019;17(1):eAO4403. https://doi.org/10.31744/einstein_journal/2019AO4403.
Oguntibeju O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45–63.
Paolisso P, Foà A, Bergamaschi L, Donati F, Fabrizio M, Chiti C, Angeli F, Toniolo S, Stefanizzi A, Armillotta M, Rucci P, Iannopollo G, Casella G, Marrozzini C, Galiè N, Pizzi C. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol. 2021;20(1):33. https://doi.org/10.1186/s12933-021-01222-9.PMID:33530978;PMCID:PMC7856791.
Yang M, Weng H, Pei Q, Jing F, Yi Q. The relationship between retinol-binding protein 4 and markers of inflammation and thrombogenesis in children with Kawasaki disease. Mediators Inflamm. 2021;11(2021):7029514. https://doi.org/10.1155/2021/7029514.PMID:33505217;PMCID:PMC7814943.
Pian G, Li H, Piao Y. Clinical significance of inflammation markers in predicting the severity of acute pancreatitis. Pancreas. 2021;50(2):201–5. https://doi.org/10.1097/MPA.0000000000001749 (PMID: 33565796).
Liu J, Liu X, Li Y, Quan J, Wei S, An S, Yang R, Liu J. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis. Biosci Rep. 2018;38(3):BSR20180172. https://doi.org/10.1042/BSR20180172.
Forget P, Khalifa C, Defour J, Latinne D, Van Pel M, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12.
Lee J, Kim N, Na S, Youn Y, Shin C. Reference values of neutrophil–lymphocyte ratio, lymphocytemonocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine. 2018;97(26):e11138.
Duman T, Aktas G, Atak B, Kocak M, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602–6. https://doi.org/10.4314/ahs.v19i1.35.
Hasan K, Mustari M, Asaduzzaman M, Gaffar A, Chanda P, Rahman M, Hannan M, Akter F, Saifudddin M, Selim S. Evaluation of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as markers of diabetic kidney disease in Bangladeshi patients with type 2 diabetes mellitus. J Diabetol. 2020;12:58–62. https://doi.org/10.4103/jod.jod_4_20.
Wang J, Chen Z, Yang K, Yang H, Tao W, Li Y, Jiang Z, Bai C, Yin Y, Duan J, Zhou Y, Geng X, Yang Y. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12:55. https://doi.org/10.1186/s13098-020-00562-y.
Liu W, Lin S, Wang L, Fang C, Lin Y, Braddock M, Zhu G, Zhang Z, Zheng M, Shen F. Platelet-to-lymphocyte ratio: a novel prognostic factor for prediction of 90-day outcomes in critically ill patients with diabetic ketoacidosis. Medicine. 2016;95(4):1–7.
Ilhan C, Citirik M, Uzel MM, Kiziltoprak H, Tekin K. The usefulness of systemic inflammatory markers as diagnostic indicators of the pathogenesis of diabetic macular edema. Arq Bras Oftalmol. 2020;83(4):299–304. https://doi.org/10.5935/0004-2749.20200051 (Epub 2020 Jul 29 PMID: 32756784).
Tsalamandris S, Antonopoulos A, Oikonomou E, Papamikroulis G, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol Rev. 2019;14(1):50–9. https://doi.org/10.15420/ecr.2018.33.1.
Baghersalimi A, Koohmanaee S, Darbandi B, Farzamfard V, Hassanzadeh Rad A, Zare R, Tabrizi M, Dalili S. Platelet indices alterations in children with type 1 diabetes mellitus. J Pediatr Hematol Oncol. 2019;41(4):e227–32. https://doi.org/10.1097/MPH.0000000000001454.
Herrera B, Rosas X, Pérez M, Castañeda M, Paulín L, Díaz R. Comparison of neutrophil/lymphocyte ratio according to degree of glycemic control in children with recent-onset type 1 and type 2 diabetes. ESPE Abstr. 2016;86:P-P2-274.
Mayer-Davis E, Kahkoska A, Jefferies C, Dabelea D, Balde N, Gong C, Craig M. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19:7–19.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5. https://doi.org/10.1186/1471-2288-5-13
Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2015;5:13. https://doi.org/10.1186/1471-2288-5-13.
Bolster NM, Bastawrous A. Chapter 25: Examining the optic fundus and assessing visual acuity and visual fields using mobile technology. Revolutionizing Tropical Medicine: Point-of-Care Tests, New Imaging Technologies and Digital Health. Wiley; 2019.
Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, Ji L, Zhan. Scoring systems to screen for diabetic peripheral neuropathy Cochrane Database Syst Rev. 2014;2018(7):CD010974.
Balder J, Lansberg P, Hof M, Wiegman A, Hutten B, Kuivenhoven J. Pediatric lipid reference values in the general population: the Dutch lifelines cohort study. J Clin Lipidol. 2018;12(5):1208–16. https://doi.org/10.1016/j.jacl.2018.05.011.
Goldstein D, Little R, Wie-dmeyer H, England J, McKenzie E. Glycated hemoglobin: methodologies and clinical applications. Clin Chem. 1986;32(10):B64-70.
Viberti G, Hill R, Jarrett R, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430–2.
Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, Wang X, Luo P, Sun J. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine. 2017;96(45):e8289. https://doi.org/10.1097/MD.0000000000008289.
Hussain M, Babar M, Akhtar L, Hussain M. Neutrophil lymphocyte ratio (NLR): a well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci. 2017;33(6):1366–70. https://doi.org/10.12669/pjms.336.12900.
Luo W, Zhang W. The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a meta-analysis and systematic review. Int J Ophthalmol. 2019;12(2):312–23. https://doi.org/10.18240/ijo.2019.02.20.
Ayhan H, Kasapkara HA, Aslan AN, Durmaz T, Keleş T, Akçay M, Akar Bayram N, Baştuğ S, Bilen E, Sarı C, Bozkurt E. Relationship of neutrophil-to-lymphocyte ratio with aortic stiffness in type 1 diabetes mellitus. Can J Diabetes. 2015;39(4):317–21. https://doi.org/10.1016/j.jcjd.2015.01.004 (Epub 2015 Mar 19 PMID: 25797110).
Yu Y, Lin Q, Ye D, Wang Y, He B, Li Y, Huang G, Zhou Z, Xiao Y. Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes. BMC Endocr Disord. 2020;20(1):158. https://doi.org/10.1186/s12902-020-00597-2.PMID:33092580;PMCID:PMC7580021.
Devamsh N, Parvathi M, Madhumathi R, Leela R. Study of neutrophil lymphocyte ratio in patients with type 2 diabetes mellitus and its correlation with glycemic control. Int J Adv Med. 2019;6:1637. https://doi.org/10.18203/2349-3933.ijam20194233.
Liu N, Sheng J, Pan T, Wang Y. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with lower extremity vascular lesions in chinese patients with type 2 diabetes. Clin Lab. 2019. https://doi.org/10.7754/Clin.Lab.2018.180804.
Fawwad A, Butt AM, Siddiqui IA, Khalid M, Sabir R, Basit A. Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes: Pakistan’s perspective. Turk J Med Sci. 2018;48(1):157–61. https://doi.org/10.3906/sag-1706-141 (PMID: 29479977).
Jaaban M, Zetoune A, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7(7):e07564. https://doi.org/10.1016/j.heliyon.2021.e07564.
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
NS: conceptualization; data curation; formal analysis investigation; software; supervision; validation; visualization; roles/writing—original draft; NR: writing—review and editing, project administration; resources. HA: methodology; project administration; resources; writing—review and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
The study was approved by the Research Ethics Committee of Ain-Shams University with an approval number R 27/2021.
Consent to participate
Informed consent was obtained from all patients for being included in the study.
Consent for publication
All authors have approved the manuscript for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Salah, N.Y., Radwan, N. & Atif, H.M. Leukocytic dysregulation in children with type 1 diabetes: relation to diabetic vascular complications. Diabetol Int 13, 538–547 (2022). https://doi.org/10.1007/s13340-021-00568-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13340-021-00568-5